跳至主要内容
临床试验/JPRN-jRCT2053230136
JPRN-jRCT2053230136招募中1 期

Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for dilated cardiomyopathy

Miyagawa Shigeru0 个研究点目标入组 4 人开始时间: 2023年11月25日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
4

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1) dilated cardiomyopathy
  • 2) NYHA class 3,4
  • 3) Patients who can not expect symptomatic improvement with standarid treatment for taget disease.To be recognized by the third party committee with experts.
  • 4) Patients who have not seen improvement in cardiac function more than 3 months after standard surgical treatment and who are at risk of worsening heart failure
  • 5) Ejecion franction<40%
  • 6) Patients who can obtain written consent from the subject to participate in the clinical trial.
  • 7) Patients who can continue to visit the study site for 52 weeks after transplantation

排除标准

  • 1) Autoimmune disease
  • 2) Allergic or hypersensitive to the immunosuppressant
  • 3) Severe infection
  • 4) Persistent shock due to worsening heart failure
  • 5) Irreversible organ failure other than heart
  • 6) Malignancy
  • 7) Pregnancy
  • 8) Alcoholic or drug addiction in recent six months
  • 9) Allergies or hypersensitivity to animals from which raw materials used
  • 10) Severe pulmonary hypertension
  • 11) Within 6 months after participating in the clinical trial
  • 12) Patients deemed unsuitable as subjects

研究者

发起方
Miyagawa Shigeru

相似试验